Depomed Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DEPOMED INC, and what generic and branded alternatives to DEPOMED INC drugs are available?
DEPOMED INC has one approved drug.
Summary for Depomed Inc
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Depomed Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depomed Inc | PROQUIN XR | ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021744-001 | May 19, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Depomed Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Depomed Inc | PROQUIN XR | ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021744-001 | May 19, 2005 | 5,972,389 | ⤷ Sign Up |
| Depomed Inc | PROQUIN XR | ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021744-001 | May 19, 2005 | 6,635,280 | ⤷ Sign Up |
| Depomed Inc | PROQUIN XR | ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021744-001 | May 19, 2005 | 6,488,962 | ⤷ Sign Up |
| Depomed Inc | PROQUIN XR | ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021744-001 | May 19, 2005 | 6,340,475 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
